JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Pulmonary Adenocarcinoma Updates: Histology, Cytology, and Grading

  • 0From the Department of Pathology, New York University Grossman School of Medicine, New York, New York.
Archives of Pathology & Laboratory Medicine +

|

December 12, 2024

|

December 12, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Accurate classification and grading of lung adenocarcinoma are crucial for patient prognosis and guiding molecular therapies. The 2021 WHO classification enhances diagnostic precision for pulmonary adenocarcinoma.

Area Of Science

  • Pulmonary Pathology
  • Oncology
  • Molecular Diagnostics

Background

  • Lung adenocarcinomas represent a diverse spectrum of tumors with varying clinical, radiologic, and molecular profiles.
  • Histologic patterns strongly correlate with prognosis, informing current classification and grading systems.
  • Targetable mutations are predominantly found in adenocarcinomas, necessitating precise diagnosis for effective treatment.

Purpose Of The Study

  • To review the rationale behind adenocarcinoma classifications in the 5th edition of the World Health Organization (WHO) Classification (2021).
  • To emphasize the importance of tumor grading and accurate diagnosis from biopsy and cytology specimens.
  • To focus on nonmucinous lung adenocarcinomas.

Main Methods

  • Literature review using PubMed.
  • Analysis of the 2021 WHO Classification of Lung Tumors.
  • Evaluation of diagnostic criteria for pulmonary adenocarcinoma.

Main Results

  • The 2021 WHO classification provides an updated framework for pulmonary adenocarcinoma.
  • A refined grading system for adenocarcinoma has demonstrated improved prognostic value.
  • Accurate diagnosis in small biopsy samples is critical for molecular testing and patient management.

Conclusions

  • The updated classification and grading system enhance the prognostic impact for pulmonary adenocarcinoma.
  • Precise diagnostic classification of adenocarcinoma is essential for molecular profiling and therapeutic decisions.
  • Accurate diagnosis from limited biopsy material is vital for optimal patient care and treatment strategies.

Related Concept Videos

Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture 01:26

161

Sputum studies are a critical part of diagnosing and treating numerous respiratory conditions. These studies involve obtaining sputum samples for analysis to identify pathogenic organisms and assess the presence of abnormal cells indicative of malignant conditions. This lesson will delve into three fundamental sputum studies: Gram Stain, Cytology, and Acid-fast Smear and Culture.
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...

Radiological Investigation III: Pulmonary Angiogram and PET Scan 01:13

86

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

Tumor Progression 02:07

6.2K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...